Facebook founder Mark Zuckerberg and his wife, Priscilla Chan, have announced a ten-year, $3bn (£2.3bn) medical research fund, designed to "cure, prevent or manage all diseases by the end of the century".
The couple unveiled the ambitious plan at the University of California, San Francisco (UCSF), during an event for the Chan Zuckerberg Initiative, the philanthropic group they launched in December 2015, when they revealed plans to give away 99 per cent of their shares in Facebook.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
One of the initiative's largest investments will be a £462m "Biohub" located at the UCSF.
The centre will "bring together scientists and engineers from Stanford, Berkeley and UCSF – who haven't collaborated in this way before – to develop tools to treat diseases", The Guardian says.
Projects already slated for investigation include the Cell Atlas, "a 'map' that describes the different types of cells that control the body's major organs", reports the BBC, and the Infectious Disease Initiative, which will "try to develop new tests and vaccines to tackle HIV, Ebola, Zika and other new diseases", adds the broadcaster.
The Chan Zuckerberg Initiative announcement follows others from tech firms planning to invest in the health sector.
Microsoft announced this week it would be trying to "solve cancer" using new tech-based research strategies at its lab in Cambridge. IBM and MIT have also revealed a partnership to develop an artificial intelligence approach to help in the care of elderly and disabled patients.
LIVE
-
Downton Abbey: The Grand Finale – a ‘comfort’ watch for fansThe Week Recommends The final film of the franchise gives viewers a chance to say goodbye
-
The Paper: new show, same 'warmth and goofiness'The Week Recommends This spin-off of the American version of The Office is ‘comfortingly and wearyingly familiar’
-
Rachel Jones: Gated Canyons – ‘riotously colourful’ works from an ‘exhilarating’ painterThe Week Recommends The 34-year-old is the first artist to take over Dulwich Picture Gallery’s main space
-
Deadly fungus tied to a pharaoh's tomb may help fight cancerUnder the radar A once fearsome curse could be a blessing
-
'Poo pills' and the war on superbugsThe Explainer Antimicrobial resistance is causing millions of deaths. Could a faeces-filled pill change all that?
-
The Y chromosome degrades over time. And men's health is paying for itUnder the radar The chromosome loss is linked to cancer and Alzheimer's
-
A bacterial toxin could be contributing to the colorectal cancer rise in young peopleUnder the radar Most exposure occurs in childhood
-
Why are more young people getting bowel cancer?The Explainer Alarming rise in bowel-cancer diagnoses in under-50s is puzzling scientists
-
Five medical breakthroughs of 2024The Explainer The year's new discoveries for health conditions that affect millions
-
Covid might be to blame for an uptick in rare cancersThe explainer The virus may be making us more susceptible to certain cancers
-
The alarming rise of cancer in young peopleUnder the radar Cancer rates are rising, and the cause is not clear
